Investigating the possible consequences of the modification of HSP60 with HNE seems warranted, given the proatherogenic role played in atherosclerosis of humans [24, 25] and LOX-1-null mice [29] by oxLDL, which shares with HSP60 the LOX-1 receptor. Here, OLR1 is linked to atherosclerosis.